<DOC>
	<DOCNO>NCT01388868</DOCNO>
	<brief_summary>The maintenance partial neuromuscular block general anesthesia neurosurgery essential intraoperative motor-evoked potential monitoring . However , precise strategy administer neuromuscular block agent obtain goal establish . Therefore , investigator try find optimal initial dose vecuronium infusion determine adequate goal neuromuscular blocking guide neuromuscular transmission module ( M-NMT Module , Datex-Ohmeda Inc , Helsinki , Finland ) .</brief_summary>
	<brief_title>Strategy Maintaining Partial Neuromuscular Blocking Adequate Motor Evoked Potential During Neurosurgery</brief_title>
	<detailed_description>The maintenance partial neuromuscular block general anesthesia neurosurgery essential intraoperative motor-evoked potential monitoring . However , precise strategy administer neuromuscular block agent obtain goal establish . Therefore , investigator try find optimal initial dose vecuronium infusion determine adequate goal neuromuscular blocking guide neuromuscular transmission module ( M-NMT Module , Datex-Ohmeda Inc , Helsinki , Finland ) . Previously , one two count response TOF stimulation consider primary goal partial neuromuscular blocking need intraoperative motor evoke potential monitoring . However , visualization twitch height response TOF stimulation possible help NMT module . For adequate motor evoke potential monitoring , twitch height T1 T2 also important simple count TOF stimulation . The investigator try establish vecuronium infusion strategy guide count TOF stimulation also twitch height T1 T2 .</detailed_description>
	<mesh_term>Vecuronium Bromide</mesh_term>
	<mesh_term>Neuromuscular Blocking Agents</mesh_term>
	<criteria>Adult Patients undergoing neurosurgery intraoperative motor evoke potential monitoring Patients undergo motor evoke potential monitoring due central peripheral neuromuscular disease ( e.g . Cerebral palsy , Myasthenia gravis , Acute spinal injury , neurologic shock ) Patients hepatic renal disease alter metabolism vecuronium Patients medication influence metabolism vecuronium ( e.g . calcium channel blocker , aminoglycoside antibiotic , Lithium , MgSO4 )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>infusion dose</keyword>
	<keyword>vecuronium</keyword>
	<keyword>motor evoke potential</keyword>
	<keyword>neuromuscular blocking agent</keyword>
</DOC>